Upcoming Events

Advances in Insulin Therapy: A Review of New Insulin Glargine 300 Units/mL in the Management of Diabetes

John R. White, Jr.

DOI: 10.2337/diaclin.34.2.86

A Case of Persistent Polyuria in an Insulin-Dependent Child With Diabetes

Swayamsidha Mangaraj, Arun Kumar Choudhury, Binoy Kumar Mohanty, and Anoj Kumar Baliarsinha

DOI: 10.2337/diaclin.34.2.109

Management of Type 2 Diabetes in the Setting of Morbid Obesity: How Can Weight Gain Be Prevented or Reversed?

Sharon W. Lahiri

DOI: 10.2337/diaclin.34.2.115

Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care

Stephen A. Brunton,  Davida F. Kruger,  and Martha M. Funnell

DOI: 10.2337/diaclin.34.1.34

Pocketbook for management of diabetes in childhood and adolescence in under-resourced countries, 2nd edition

Treatment Approach to Patients With Severe Insulin Resistance

Timothy J. Church  and Stuart T. Haines

DOI: 10.2337/diaclin.34.2.97

Alzheimer’s Disease Is Type 3 Diabetes—Evidence Reviewed

Suzanne M. de la Monte, M.D., M.P.H.1–3 and Jack R. Wands, M.D.3

J Diabetes Sci Technol 2008;2(6):1101-1113

The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience

William R. Hiatt, M.D., Sanjay Kaul, M.D., and Robert J. Smith, M.D.

DOI: 10.1056/NEJMp1309610

Diabetic Sensory and Motor Neuropathy

Aaron I. Vinik, M.D., Ph.D.

N Engl J Med 2016;374:1455-64.

DOI: 10.1056/NEJMcp1503948

Acid–Base Problems in Diabetic Ketoacidosis

Kamel S. Kamel, M.D., and Mitchell L. Halperin, M.D.

N Engl J Med 2015;372:546-54.

DOI: 10.1056/NEJMra1207788

Rare Presentations of Ketoacidosis: Diabetic Ketoalkalosis and Ketoacidosis Secondary to Fasting and Muscular Dystrophy

Mads Vandsted Svart, Thomas Schmidt Voss, Michael Bayat, Lene Ring Madsen, Lone Thing Andersen, Per Løgstrup Poulsen, and Niels Møller

DOI: 10.2337/diaclin.33.1.37

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

DOI: 10.1161/01.cir.0000437738.63853.7a

This Time, FDA Panel Endorses Diabetes Drug Dapagliflozin

World First Approval for Fenofibrate in Diabetic Retinopathy

FDA Lifts Rosiglitazone Prescribing Restrictions (November 25, 2013)


Copyrights - Oman Diabetes Association © 2019 جميع الحقوق محفوظة - الجمعية العمانية لمرض السكري